3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
147
Lymphoma, Follicular
41
Lymphoma, Large B-Cell, Diffuse
37
Lymphoma, B-Cell, Marginal Zone
24
Recurrence
18
Lymphoma, Mantle-Cell
17
Lymphoma
17
Neoplasms, Plasma Cell
15
Lymphoma, Non-Hodgkin
15
Leukemia, Lymphocytic, Chronic, B-Cell
11
Neoplasms
9
Smoldering Multiple Myeloma
8
Lymphoma, B-Cell
8
Neoplasm, Residual
5
Burkitt Lymphoma
5
Leukemia, Plasma Cell
4
Waldenstrom Macroglobulinemia
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell, Cutaneous
3
Plasmacytoma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Lymphoma, T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Urinary Bladder Neoplasms
1
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Lenalidomide
×
1 year
×
Clear all
No trials found.